Saluda Medical Funding: $664M Raised, Series U (2025)

Saluda Medical funding overview

Saluda Medical is based in Artarmon, Nsw, Australia. Saluda Medical has raised $664M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series U announced in January 2025. The round record for Saluda Medical runs through 2025; nothing later has been disclosed. Investors on record include Redmile Group, Boston Scientific, BioScience Managers, Medtronic, Action Potential Venture Capital, Wellington Management and 4 others. 10 distinct backers are named across the disclosed rounds.

Saluda Medical at a glance

Total raised

$664M

Latest round

Series U

Latest round date

January 2025

Headquarters

Artarmon, Nsw, Australia

Notable investors

Redmile Group, Boston Scientific, BioScience Managers, Medtronic, Action Potential Venture Capital, Wellington Management, RA Capital, Seventure Partners

Frequently asked about Saluda Medical funding

How much has Saluda Medical raised?

Saluda Medical has raised $664M in total disclosed funding across the rounds on record.

Who has invested in Saluda Medical?

Redmile Group, Boston Scientific, BioScience Managers, Medtronic, Action Potential Venture Capital, Wellington Management are named among the investors backing Saluda Medical.

What was the latest Saluda Medical funding round?

The most recent disclosed round is a Series U, announced in January 2025.

Where is Saluda Medical based?

Saluda Medical is based in Artarmon, Nsw, Australia.

When did Saluda Medical last raise?

The last disclosed Saluda Medical round closed in January 2025 at Series U.

We update the Saluda Medical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Artarmon and their backers are listed below.

Saluda Medical funding history

3 disclosed rounds on record, including 2 reported through SEC Form D filings.

1. Filed November 2025 — Private financing. $30M sold of a $30M offering. 26 investors reported. SEC Form D filing
2. January 2025 — Series D+. $100M.
3. Filed April 2023 — Private financing. $150M sold of a $150M offering. 18 investors reported. SEC Form D filing

SEC Form D filings report the amount sold against a stated offering size, which can differ from press-reported round totals, and they do not name the round — those entries appear as Private financing.

Companies related to Saluda Medical (18)

• Kymera Therapeutics
• ElevateBio
• BioNTech
• BioNTech.de
• Atea Pharmaceuticals
• Mammoth Biosciences
• Impulse Dynamics
• Nuvation Bio
• Boundless Bio
• Escient Pharmaceuticals
• Science 37
• Lycia Therapeutics
• Verve Therapeutics
• Neuron23
• ADARx Pharmaceuticals
• Abcuro
• Xeris Pharmaceuticals
• Amunix

Browse related funding lists (5)

• Companies that raised 500m 1b
• Companies funded in 2025
• Companies backed by Medtronic
• Companies backed by Redmile Group
• Companies backed by Wellington Management

Company funding database · Investor directory · Founder database · Mega-rounds 2026